Skip to main content

Advertisement

SpringerLink
Log in

Adherence to ACIP Recommendation for Human Papillomavirus Vaccine Among US Adolescent Girls

  • Original Paper
  • Published:
Journal of Community Health Aims and scope Submit manuscript

Abstract

The objective of this study was to examine correlates of human papillomavirus (HPV) vaccine use according to Advisory Committee on Immunization Practices (ACIP)’s recommendations among US adolescent girls. We used National Immunization Survey of Teens 2013 data. Based on provider-verified (n = 9403) information, 57.3, 39.1 and 19.0 % of adolescent girls, initiated, completed and completed the HPV vaccine according to ACIP’s recommendation (by age 12), respectively. Hispanic race/ethnicity, a physician recommendation for HPV vaccine and ≥1 influenza vaccine in the past 3 years were all associated with a higher likelihood of compliance with ACIP’s recommendation. Girls from a larger family and those whose immunization provider was a STD/school/teen clinic were less likely to receive the vaccine at the recommended age compared to a girl raised in a smaller sized family and received immunization from a hospital facility, respectively. Only one-fifth of 13–17 yo girls receive the HPV vaccine by age 12 as recommended by ACIP. Physician visits and influenza vaccination settings are opportunities to improve vaccine series completion at the recommended age.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Garland, S. M., Steben, M., Sings, H. L., et al. (2009). Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. Journal of Infectious Diseases, 199(6), 805–814.

    Article  PubMed  Google Scholar 

  2. Bosch, F. X., Burchell, A. N., Schiffman, M., et al. (2008). Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine, 26(Suppl 10), K1–K16.

    Article  PubMed  Google Scholar 

  3. Joura, E. A., Giuliano, A. R., Iversen, O. E., et al. (2015). A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women. New England Journal of Medicine, 372(8), 711–723.

    Article  CAS  PubMed  Google Scholar 

  4. Reagan-Steiner, S., Yankey, D., Jeyarajah, J., et al. (2015). National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 Years: United States, 2014. MMWR Morbidity Mortality Weekly Report, 64(29), 784–792.

    Article  PubMed  Google Scholar 

  5. Hopkins, T. G., & Wood, N. (2013). Female human papillomavirus (HPV) vaccination: Global uptake and the impact of attitudes. Vaccine, 31(13), 1673–1679.

    Article  PubMed  Google Scholar 

  6. Markowitz, L. E., Dunne, E. F., Saraiya, M., Centers for Disease Control and Prevention (CDC). et al. (2014). Human papillomavirus vaccination: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recommendation Report, 63(RR-05), 1–30.

    Google Scholar 

  7. Lehtinen, M., Paavonen, J., Wheeler, C. M., et al. (2012). Overall efficacy of HPV-16/18 AS04 adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncology, 13(1), 89–99.

    Article  CAS  PubMed  Google Scholar 

  8. Block, S. L., Nolan, T., Sattler, C., et al. (2006). Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics, 118(5), 2135–2145.

    Article  PubMed  Google Scholar 

  9. Pedersen, C., Petaja, T., Strauss, G., et al. (2007). Immunization of early adolescent females with human papillomavirus type 16 and 18 L1 virus-like particle vaccine containing AS04 adjuvant. Journal of Adolescent Health, 40(6), 564–571.

    Article  PubMed  Google Scholar 

  10. Dunne, E. F., Unger, E. R., Sternberg, M., et al. (2007). Prevalence of HPV infection among females in the United States. Journal of American Medical Association, 297(8), 813–819.

    Article  CAS  Google Scholar 

  11. Rahman, M., McGrath, C. J., Hirth, J. M., & Berenson, A. B. (2015). Age at HPV vaccine initiation and completion among US adolescent girls: Trend from 2008 to 2012. Vaccine, 33(5), 585–587.

    Article  PubMed  Google Scholar 

  12. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, National Center for Health Statistics. (2013). National immunization survey-teen. A user’s guide for the 2011 public use data file. Retrieved from http://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NIS/NISPUF13_DU.pdf.

  13. Jain, N., Singleton, J. A., Montgomery, M., & Skalland, B. (2009). Determining accurate vaccination coverage rates for adolescents: The National Immunization Survey-Teen 2006. Public Health Reports, 124(5), 642–651.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kahn, J. A., Ding, L., Huang, B., Zimet, G. D., Rosenthal, S. L., & Frazier, A. L. (2009). Mothers’ intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics, 123(6), 1439–1445.

    Article  PubMed  Google Scholar 

  15. Daley, M. F., Crane, L. A., Markowitz, L. E., et al. (2010). Human papillomavirus vaccination practices: A survey of US physicians 18 months after licensure. Pediatrics, 126(3), 425–433.

    Article  PubMed  Google Scholar 

  16. Vadaparampil, S. T., Kahn, J. A., Salmon, D., et al. (2010). Missed clinical opportunities: Provider recommendations for HPV vaccination for 11–12 year old girls are limited. Vaccine, 29(47), 8634–8641.

    Article  Google Scholar 

  17. Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2010). Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine, 28(4), 989–995.

    Article  PubMed  Google Scholar 

Download references

Funding

Dr. Hirth is supported by a research career development award (K12HD052023: Building Interdisciplinary Research Careers in Women’s Health Program—BIRCWH, PI: Berenson) from the Office of Research on Women’s Health (ORWH), the Office of the Director (OD), the National Institute of Allergy and Infectious Diseases (NIAID), and NICHD at the National Institutes of Health.

Author Contributions

MR contributed toward the conception and design of the study, conducted data analysis, drafted and revised the manuscript and approved the final version. JMH and ABB contributed toward introduction and discussion, revised the manuscript and approved the final version.

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, The Center for Interdisciplinary Research in Women’s Health, The University of Texas Medical Branch, Galveston, TX, USA

    Mahbubur Rahman, Jacqueline M. Hirth & Abbey B. Berenson

  2. Center for Clinical Epidemiology, St. Luke’s International University, 3-6-2 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

    Mahbubur Rahman

Authors
  1. Mahbubur Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jacqueline M. Hirth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abbey B. Berenson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mahbubur Rahman.

Ethics declarations

Conflict of Interest

None reported.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rahman, M., Hirth, J.M. & Berenson, A.B. Adherence to ACIP Recommendation for Human Papillomavirus Vaccine Among US Adolescent Girls. J Community Health 42, 385–389 (2017). https://doi.org/10.1007/s10900-016-0267-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10900-016-0267-6

Keywords

Search

Navigation